Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Exercise and physical therapy in early management of Parkinson disease

Alonso-Frech F, Sanahuja JJ, Rodriguez AM.

Neurologist. 2011 Nov;17(6 Suppl 1):S47-53. doi: 10.1097/NRL.0b013e31823968ec.

Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies

Herrero MT, Pagonabarraga J, Linazasoro G.

Neurologist. 2011 Nov;17(6 Suppl 1):S54-66. doi: 10.1097/NRL.0b013e31823968fc.

Nonmotor disorders and their correlation with dopamine: can they be treated by currently available methods?

Martinez-Castrillo JC, Vela L, del Val J, Alonso-Canovas A.

Neurologist. 2011 Nov;17(6 Suppl 1):S9-17. doi: 10.1097/NRL.0b013e318239669f.

The aging brain and neurodegenerative diseases

Duncan GW.

Clin Geriatr Med. 2011 Nov;27(4):629-44. doi: 10.1016/j.cger.2011.07.008.

[Research advance of the protective role of PACAP in the nervous system diseases]

Mao SS, Zhang YM.

Sheng Li Ke Xue Jin Zhan. 2011 Aug;42(4):276-80.

Parkinson disease: the enteric nervous system spills its guts

Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R.

Neurology. 2011 Nov 8;77(19):1761-7. doi: 10.1212/WNL.0b013e318236ef60.

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder

Calahorro F, Ruiz-Rubio M.

Invert Neurosci. 2011 Dec;11(2):73-83. doi: 10.1007/s10158-011-0126-1. Epub 2011 Nov 8.

Mitochondrial pathology in Parkinson's disease

Schapira AH.

Mt Sinai J Med. 2011 Nov-Dec;78(6):872-81. doi: 10.1002/msj.20303.

Polyphenols and neuroprotection against ischemia and neurodegeneration

Lin B.

Mini Rev Med Chem. 2011 Dec;11(14):1222-38. doi: 10.2174/13895575111091222.

Helicobacter pylori eradication for Parkinson's disease

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD008453. doi: 10.1002/14651858.CD008453.pub2.

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008454. doi: 10.1002/14651858.CD008454.pub2.

Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials

Rees K, Stowe R, Patel S, Ives N, Breen K, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD008535. doi: 10.1002/14651858.CD008535.pub2.

Thalamic contributions to Basal Ganglia-related behavioral switching and reinforcement

Smith Y, Surmeier DJ, Redgrave P, Kimura M.

J Neurosci. 2011 Nov 9;31(45):16102-6. doi: 10.1523/JNEUROSCI.4634-11.2011.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias